Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Claimed Company
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more
Karyopharm Therapeutics Awards
Karyopharm Therapeutics won 3 awards in 2023 and 1 award in 2022. In 2023, Karyopharm Therapeutics won for Best Company Compensation, Happiest Employees and Best Company Perks & Benefits. In 2022, Karyopharm Therapeutics won for Best Company Compensation. Based on 2,628 ratings and 90 participants, employees at Karyopharm Therapeutics are very satisfied with their work experience. The overall culture score, 79/100 or A-, incorporates employee ratings based on their feedback on the Outlook, Leadership, Gender and more.
Comparably Awards are provided yearly to top performing company cultures based on real feedback from their employees.
Best Company Compensation 2023 (Small & Midsize Companies)Karyopharm TherapeuticsBest Company Compensation
Happiest Employees 2023 (Small & Midsize Companies)Karyopharm TherapeuticsHappiest Employees
Best Company Perks & Benefits 2023 (Small & Midsize Companies)Karyopharm TherapeuticsBest Company Perks & Benefits
Help Your Company Win 2025 Awards
Anonymously rate your experience & help make Karyopharm Therapeutics a better place to work.
Awards Press for Karyopharm Therapeutics
×